Erratum to: Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany

By Falkenhorst G.   Harder T.   Remschmidt C.   Terhardt M.   Zepp F.   Ledig T.   Wicker S.   Keller-Stanislawski B.   Mertens T.  

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 57, Iss. 4, 2014-04 ,pp. : 473-474

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles-Mumps-Rubella Vaccine Given Concomitantly at 12 years of Age

By Parment Per Arne   Svahn Anita   Rudén Ulla   Bråkenhielm Görel   Storsaeter Jann   Åkesson Lena   Linde Annika  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 736-742

Informa Healthcare

Access to resources Recommend Favorite

Self-Immunization with Live Attenuated Influenza Vaccine in a Mass Vaccination Clinic

By  

Disaster Medicine and Public Health Preparedness, Vol. 7, Iss. 2, 2013-04 ,pp. : 215-217

Cambridge University Press

Access to resources Recommend Favorite

Do delays in data availability limit the implementation of near real‐time vaccine safety surveillance using the Clinical Practice Research Datalink?

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 25-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia

By Alvis Guzmán Nelson   De La Hoz Restrepo Fernando   Vivas Consuelo David  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 20, Iss. 4, 2006-10 ,pp. : 248-255

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite